Bortezomib 2mg Injection Myezom

The medication bortezomib is used to treat multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat people with mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system) Bortezomib belongs to the class of medicines known as antineoplastic agents..

• The injection site may cause dizziness
• lightheadedness
• nausea
• vomiting, lack of appetite
• diarrhoea
• constipation,
• weariness
• weakness
• or pain/redness
• Common adverse effects include nausea
• vomiting, and diarrhea
• Your doctor may recommend medication to prevent or alleviate nausea, vomiting
• diarrhoea in some circumstances.

A therapy cycle is defined as three weeks. – Between consecutive Bortezomib 2mg Injection doses, a minimum of 72 hours should pass. – Two further cycles (for a total of eight cycles) are indicated for individuals who had a response at cycle 6.

Multiple myeloma is an immune-system malignancy that causes the following symptoms:
Your body destroys bone at a faster rate than it regenerates new bone if you have multiple myeloma. This makes bones weak and painful, increasing the chances of them breaking. 2 mg of myezom Injections can be combined with other cancer treatments like chemotherapy to treat the condition.

It’s an important part of your treatment and has been proved to help people with multiple myeloma live longer. The cancerous cells will be killed, and the medication will prevent them from multiplying and spreading to other parts of the body. It will also help to limit cancer progression. Follow your medication’s instructions to the letter to get the most out of it.

Check this Anti cancer product Mylosome 2mg Injection or you may explore more Anti cancer products by clicking here

We are an exporter from India and work in many countries, such as the UAE, Oman, Qatar, Myanmar, Saudi Arabia, the Netherlands, Albania, Saint Lucia, Jordan, Romania, and South Africa.